MTOR and non-small cell lung carcinoma: The over‐expression of T cell differentiation protein 2 (MAL2), belonging to the MAL protein family, induces activation of the MAPK/mTOR signalling pathway, promotes ribosome biogenesis and facilitates proliferation in non‐small cell lung cancer (NSCLC).19